Alder Biopharmaceuticals
Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. In early 2018, the company made a public stock offering, aiming to raise US$250 million. The company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Alder Biopharmaceuticals
Alder Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Alder specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. In early 2018, the company made a public stock offering, aiming to raise US$250 million. The company identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas.
has abstract
Alder Biopharmaceuticals is a ...... deal valued at $1.95 billion.
@en
Wikipage page ID
52,777,355
page length (characters) of wiki page
Wikipage revision ID
1,019,213,573
Link from a Wikipage to another Wikipage
wikiPageUsesTemplate
subject
comment
Alder Biopharmaceuticals is a ...... nd inflammatory disease areas.
@en
label
Alder Biopharmaceuticals
@en